Type 1 diabetes prevention: A goal dependent on accepting a diagnosis of an asymptomatic disease

Diabetes

Volumn 65, Issue 11, 2016, Pages 3233-3239

  Ziegler, Anette G ^a,b   Bonifacio, Ezio ^c,d,e   Powers, Alvin C ^f,g,h   Todd, John A ⁱ   Harrison, Leonard C ^j   Atkinson, Mark A ^k  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e Forschergruppe Diabetes eV   (Germany)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j UNIVERSITY OF MELBOURNE   (Australia)

^k UNIVERSITY OF FLORIDA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; INSULIN;

ASYMPTOMATIC DISEASE; CELL ENCAPSULATION; EARLY DIAGNOSIS; HISTORY; HUMAN; IMMUNOTHERAPY; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; STEM CELL; ANALYSIS; BLOOD; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS, TYPE 1; GLUCOSE BLOOD LEVEL;

ASYMPTOMATIC DISEASES; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN;

EID: 84994235308     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db16-0687     Document Type: Review

References (37)

1. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet 2014; 383:69-82
2. Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013;309: 2473-2479
3. Steck AK, Vehik K, Bonifacio E, et al.; TEDDY Study Group. Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes Care 2015;38:808-813
4. Bonifacio E. Predicting type 1 diabetes using biomarkers. Diabetes Care 2015;38:989-996
5. Insel RA, Dunne JL, Atkinson MA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 2015;38:1964-1974
6. Tuomilehto J. The emerging global epidemic of type 1 diabetes. Curr Diab Rep 2013;13:795-804
7. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G; EURODiAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-2033
8. Vehik K, Haller MJ, Beam CA, et al.; DPT-1 Study Group. Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood. Diabetes Care 2011;34:358-362
9. Ziegler AG, Bonifacio E; BABYDiAB-BABYDiET Study Group. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 2012;55:1937-1943
10. Parikka V, Näntö-Salonen K, Saarinen M, et al. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 2012;55:1926-1936
11. Krischer JP, Lynch KF, Schatz DA, et al.; TEDDY Study Group. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia 2015;58:980-987
12. Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005;352: 2598-2608
13. Westerberg DP. Diabetic ketoacidosis: evaluation and treatment. Am Fam Physician 2013;87:337-346
14. Choleau C, Maitre J, Elie C, et al.; le Groupe d'étude de l'aide aux jeunes diabétiques (AJD Study Group). Ketoacidosis at time of diagnosis of type 1 diabetes in children and adolescents: effect of a national prevention campaign. Arch Pediatr 2015;22:343-351 [In French]
15. Cameron FJ, Wherrett DK. Care of diabetes in children and adolescents: controversies, changes, and consensus. Lancet 2015;385:2096-2106
16. Winkler C, Schober E, Ziegler AG, Holl RW. Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies. Pediatr Diabetes 2012;13:308-313
17. Elding Larsson H, Vehik K, Bell R, et al.; TEDDY Study Group; SEARCH Study Group; Swediabkids Study Group; DPV Study Group; Finnish Diabetes Registry Study Group. Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care 2011;34:2347-2352
18. Chan CL, Taki I, Dong F, et al. Comparison of metabolic outcomes in children diagnosed with type 1 diabetes through research screening (Diabetes Autoimmunity Study in the Young [DAISY]) versus in the community. Diabetes Technol Ther 2015;17:649-656
19. Silverstein J, Klingensmith G, Copeland K, et al.; American Diabetes Association. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005;28:186-212
20. Meehan C, Fout B, Ashcraft J, Schatz DA, Haller MJ. Screening for T1D risk to reduce DKA is not economically viable. Pediatr Diabetes 2015;16:565-572
21. Bingley PJ, Rafkin LE, Matheson D, et al.; TrialNet Study Group. Use of dried capillary blood sampling for islet autoantibody screening in relatives: a feasibility study. Diabetes Technol Ther 2015;17:867-871
22. Marcus P, Yan X, Bartley B, Hagopian W. LIPS islet autoantibody assays in highthroughput format for DASP 2010. Diabetes Metab Res Rev 2011;27:891-894
23. Winkler C, Krumsiek J, Buettner F, et al. Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes. Diabetologia 2014; 57:2521-2529
24. Zhao Z, Miao D, Michels A, et al. A multiplex assay combining insulin, GAD, IA-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease. J Immunol Methods 2016;430:28-32
25. Zhang B, Kumar RB, Dai H, Feldman BJ. A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes. Nat Med 2014;20:948-953
26. Insel RA, Dunne JL, Ziegler AG. General population screening for type 1 diabetes: has its time come? Curr Opin Endocrinol Diabetes Obes 2015;22:270-276
27. Raab J, Haupt F, Scholz M, et al.; Fr1da Study Group. Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study. BMJ Open 2016;6:e011144
28. Lampasona V, Schlosser M, Mueller PW, et al. Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8. Clin Chem 2011;57:1693-1702
29. Törn C, Mueller PW, Schlosser M, Bonifacio E, Bingley PJ; Participating Laboratories. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 2008;51:846-852
30. Schlosser M, Mueller PW, Achenbach P, Lampasona V, Bingley PJ; Participating Laboratories. Diabetes Antibody Standardization Program: first evaluation of assays for autoantibodies to IA-2b. Diabetes Care 2011;34:2410-2412
31. Hamman RF, Bell RA, Dabelea D, et al.; SEARCH for Diabetes in Youth Study Group. The SEARCH for Diabetes in Youth study: rationale, findings, and future directions. Diabetes Care 2014;37:3336-3344
32. Honeyman MC, Harrison LC, Drummond B, Colman PG, Tait BD. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol Med 1995;1:576-582
33. Kaddis JS, Pugliese A, Atkinson MA. A run on the biobank: what have we learned about type 1 diabetes from the nPOD tissue repository? Curr Opin Endocrinol Diabetes Obes 2015;22:290-295
34. Campbell-Thompson M. Organ donor specimens: What can they tell us about type 1 diabetes? Pediatr Diabetes 2015;16:320-330
35. Arif S, Leete P, Nguyen V, et al. Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes. Diabetes 2014;63:3835-3845
36. Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L. The many faces of diabetes: a disease with increasing heterogeneity. Lancet 2014;383:1084-1094
37. Giannopoulou EZ, Winkler C, Chmiel R, et al. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes. Diabetologia 2015;58:2317-2323